Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2019 Earnings Conference Call February 27, 2020 8:00 AM ET Company Participants Juli Miller - Director of Investor Relations Adrian Rawcliffe - Chief Executive Officer Helen Tayton-Martin - Chief Business Officer Elliot Norry - Chief Medical Officer Conference Call Participants Tony Butler - Roth Capital Marc Frahm - Cowen and Company Kelsey Goodwin - Guggenheim Securities James Shannon - Citi Jonathan Chang - SVB Leerink Operator Ladies and gentlemen, thank you ...